Dr. Vivek Borse

About

I have over twelve years of professional experience in research and development in the field of healthcare-related point-of-care in vitro diagnostics and medical devices. I currently lead the process development team at Achira Labs Pvt. Ltd., a company that specializes in developing innovative and affordable diagnostic solutions for global health challenges.

My core competencies include the design and synthesis of polymeric hydrogel-based sensors, dye-antibody conjugation techniques, formulation stability, advanced freeze-drying techniques (preparation of LyoBeads & LyoPellets), nanobiotechnology, lateral flow assay development, and synthesis and conjugation of nanoparticles. I have a strong track record of scientific publications, patents, trademarks, and research projects at premier institutions in India (i.e., IIT Bombay, IIT Guwahati, NIPER Mohali, NIPER Hyderabad). I am passionate about creating impactful and accessible diagnostic products that can improve the quality of life and health outcomes of millions of people around the world.

Employment

Employment history is unavailable.

Education

• Indian Institute of Technology Bombay Doctor of Philosophy
  2013 - Present
• National Institute of Pharmaceutical Education and Research Master of Technology (Pharm.)
  2010 - 2012
• R C Patel Institute of Pharmaceutical Education and Research Bachelor pf Pharmacy
  2006 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (26)

• Introduction to Nanoparticles as a Potential Carrier for Brain Targeting
  2024 DOI: 10.1007/978-981-97-2859-6_3
  +Save
• Enzymatic Biosensor Platforms for Diagnosis of Heart Diseases
  2023 DOI: 10.1007/978-981-15-6982-1_3
  +Save
• Outlook of various diagnostics and nanodiagnostic techniques for COVID-19
  Biosensors and Bioelectronics: X 2022 DOI: 10.1016/j.biosx.2022.100276
  +Save
• Role of IL-6 and IL-8 biomarkers for optical and electrochemical based point-of-care detection of oral cancer
  Biosensors and Bioelectronics: X 2022 DOI: 10.1016/j.biosx.2022.100212
  +Save
• Strategies for sensitivity enhancement of point-of-care devices
  Biosensors and Bioelectronics: X 2022 DOI: 10.1016/j.biosx.2021.100098
  +Save
• Lymphatic transport system to circumvent hepatic metabolism for oral delivery of lipid-based nanocarriers
  Journal of Drug Delivery Science and Technology 2021 DOI: 10.1016/j.jddst.2021.102934
  +Save
• Perspectives of characterization and bioconjugation of gold nanoparticles and their application in lateral flow immunosensing
  Drug Delivery and Translational Research 2020 DOI: 10.1007/s13346-020-00771-y
  +Save
• Arginolipid: A membrane‐active antifungal agent and its synergistic potential to combat drug resistance in clinical Candida isolates
  Archiv der Pharmazie 2020 DOI: 10.1002/ardp.201900180
  +Save
• Current status of point-of-care diagnostic devices in the Indian healthcare system with an update on COVID-19 pandemic
  Sensors International 2020 DOI: 10.1016/j.sintl.2020.100015
  +Save
• Nanobiotechnology Advancements in Lateral Flow Immunodiagnostics
  Nanobiomaterial Engineering 2020 DOI: 10.1007/978-981-32-9840-8_10
  +Save